Molly Zimmerman, PhD Linkedin Twitter Google Dr. Zimmerman is the director of the Neuropsychology Laboratory. She is a licensed clinical neuropsychologist who enjoys engaging in a wide-range of research, teaching, and clinical practice activities. Her research interests explore the many ways in which cognitive abilities interact with medical conditions such as insomnia, sleep apnea, dementia, […]
Tomohiro Nakamura, PhD Linkedin Our group is focused on a nitric oxide (NO)-mediated posttranslational modification called S-nitrosylation, whereby an NO group reacts with a critical cysteine thiol of a specific protein to regulate its function, akin to the effect of phosphorylation. Excessive generation of NO in the nervous system may constitute a fundamental pathological process
Robert Rissman, PhD Linkedin Google My research at UCSD is split into several parts that I balance relatively equally. The goal of my basic science research is on novel biomarker discovery in Alzheimer’s Disease (AD) and preclinical studies in experimental neuropathology, focused primarily on Alzheimer’s disease. A major focus of my lab in AD biomarkers
Karin Schon, PhD Linkedin Google Dr. Schon is the director of the Brain Plasticity and Neuroimaging Laboratory. She also holds appointments with the Department of Psychological and Brain Sciences, the Center for Memory and Brain, and the Undergraduate and Graduate Programs in Neuroscience. She received her Ph.D. in 2005 and did her postdoctoral research with Prof. Chantal Stern at
Jungsu Kim, PhD Linkedin Facebook Twitter Google Dr. Kim is the P. Michael Conneally Professor of Medical and Molecular Genetics. Dr. Kim graduated Summa Cum Laude in 2000 from Pohang University of Science & Technology in Korea with a bachelor’s degree in life science. He earned his Ph.D. from Mayo Clinic College of Medicine in 2007
Masashi Kitazawa, PhD Google My primary research emphasis centers on understanding the molecular pathogenesis of neurodegenerative diseases, such as Alzheimer’s disease (AD) and the impact of neuroinflammation elicited endogenously by disruption of normal immune responses by aging or by exogenous environmental factors, such as chronic exposure to environmental chemicals and toxicants. By using multiple experimental
Joseph Goveas, MD Google Dr. Goveas is a fellowship-trained, board-certified geriatric psychiatrist with an interest in elucidating the brain-behavior relationships in normal aging, prolonged grief disorder (a.k.a. complicated grief), and late-life depression. Our current research focuses on improving understanding of the neurobiological markers that may help us predict who, following the death of a loved
Adam M. Brickman, PhD Linkedin Twitter Dr. Brickman uses advanced neuroimaging techniques to understand cognitive aging and dementia. He is particularly interested in white matter abnormalities and the intersection between vascular disease and Alzheimer’s disease. Ongoing Research: The effect of age on neuromorphology and its cognitive consequences. His current research efforts focus primarily on “normal”
Mark Burns, PhD Linkedin Twitter Google Dr Burns’ lab investigates the link between traumatic brain injury (TBI) and Alzheimer’s disease. Exposure to TBI can quadruple the risk of developing Alzheimer’s disease, and amyloid plaques similar to those seen in Alzheimer’s disease have been found in the brain of TBI fatalities. Dr Burns’ lab recently found
Corinne Engelman, MSPH, PhD Linkedin Facebook Google Dr. Engelman earned her MS in Public Health (2002) and PhD in Epidemiology (2006) from the University of Colorado Health Sciences Center and has been a faculty member in Population Health Sciences at UW-Madison since 2007. Her research focuses on the study design and data analysis of genetic,
